News for iPower Inc. (IPW)

Discover iPower's strong Q2 2025 performance, driven by SuperSuite's 20% revenue contribution, supply chain optimizations, and channel diversification.

iPower Inc. (NASDAQ:IPW) Q2 2025 Earnings Conference Call February 13, 2025 4:30 PM ETCompany ParticipantsKevin Vassily - Chief Financial OfficerLawrence...

We recently published a list of the 12 Best E-Commerce Stocks to Buy According to Analysts. In this article, we are going to take a look at where iPower Inc.

We recently compiled a list of the 8 Best Vertical Farming and Hydroponic Stocks to Invest In. In this article, we are going to take a look at where iPower Inc. (NASDAQ:IPW) stands against the other...

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.70%

iPower Inc. (NASDAQ:IPW) Q1 2025 Results Conference Call November 14, 2024 4:30 PM ETCompany ParticipantsLawrence Tan - Chairman and Chief Executive...

iPower (IPW) reports fiscal first quarter 2025 results with GAAP EPS and revenue missing expectations, but gross margin improving and debt decreasing.

iPower renews credit facility with JPMorgan Chase, extending maturity to 2027. $15M commitment, with potential to increase to $40M.

**media[458189]**

RANCHO CUCAMONGA, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- iPower Inc. (Nasdaq: IPW) (“iPower” or the “Company”), a tech and data-driven ecommerce...

IPower Inc. (IPW) concluded the recent trading session at $1.42, signifying a -1.39% move from its prior day's close.

IPower Inc. (IPW) closed at $1.44 in the latest trading session, marking a +0.7% move from the prior day.

IPower Inc. (IPW) concluded the recent trading session at $1.51, signifying a -0.66% move from its prior day's close.

LITB saw its stock price surge by 5.26%, trading at $2.80 per share with a trading volume of 4,997 shares and a turnover rate of 0.03%. The stock's recent finan

In this article, we will take a look at the 18 Biggest Vertical Farming Companies.

Loading... Loading... Shares of Ovid Therapeutics Inc OVID dipped 65.7% to $1.1285 after Takeda’s Skyline study in Dravet syndrome missed its primary endpoin...

Loading... Loading... Shares of Nurix Therapeutics, Inc. NRIX rose sharply in today's pre-market trading after the company announced results from its ongoing c...

Loading... Loading... Shares of Virios Therapeutics, Inc. VIRI fell sharply during Monday's session after the company priced a $1.7 million public offering of ...

Loading... Loading... Shares of Wix.com Ltd. WIX rose sharply in today's pre-market trading as the company posted upbeat results for its first quarter and rais...